Ann: March Quarterly Report & Appendix 4C, page-33

This is the biggest problem. They have actually achieved quite a lot.

However all this has not led to any improvement on thier bottom line. That is the biggest concern.

When you analyse all there deals it looks great on paper, but when you look deeper into it there is very little substance in it where it'll increase sales/profits significantly.

E .g chemsave deal. 150 locations blah blah blah. When U look at it they are all regional pharmacies. Then they are all independent pharmacies operating under the chemsave banner. So they have absolutely no obligation to stock any of au8's products.

What to next? Will the fruits of thier labour pay off? If so it had better soon. They are far from tipping point to break even let alone make a profit to justify valuation of $50million it where someoeioke bought in at $150million.